Reshape Lifesciences RSLS reported its Q1 earnings results on Monday, May 23, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Reshape Lifesciences missed estimated earnings by 123.53%, reporting an EPS of $-0.38 versus an estimate of $-0.17.
Revenue was down $781.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 1.48% increase in the share price the next day.
To track all earnings releases for Reshape Lifesciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.